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Articular cartilage repair: are the intrinsic biological constraints
undermining this process insuperable?
By Ernst B. Hunziker
M. E. Mu¨ller-Institute for Biomechanics, University of Bern, Switzerland
Summary
This article reviews the experimental and clinical strategies currently in use or under development for the treatment
of articular cartilage lesions. The vast majority of protocols under investigation pertain to the treatment of
full-thickness defects (i.e., those which penetrate the subchondral bone and trabecular–bone spaces) rather than
partial-thickness ones (i.e., those which are confined to the substance of articular cartilage tissue itself). This bias
probably reflects the circumstance that partial-thickness defects do not heal spontaneously whereas full-thickness ones
below a critical size do, albeit transiently. And it is, of course, a seemingly easier task to manipulate a process which
is readily set in train than it is to overcome an induction-problem which Nature herself has not solved. Indeed, the
reasons for this inert state of partial-thickness defects have only recently been elucidated, and these are briefly
discussed. However, the main body of this review deals with the various transplantation concepts implemented for the
repair of full-thickness defects. These fall into two broad categories: tissue-based (entailing the grafting of perichon-
drial, periosteal, cartilage or bone-cartilage material) and cell-based (utilizing chondroblasts, chondrocytes, periochon-
drial cells or mesenchymal stem cells). Cell-based systems are further subdivided according to whether cells are
transplanted within a matrix (biodegradable, non-biodegradable or synthetic) or free in suspension. Thus far, the
application of cell suspensions has always been combined with the grafting of a periosteal flap. The strengths and
weaknesses of each concept are discussed.
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TRAUMA and disease of the synovial joint fre-
quently involve structural damage to the articular
cartilage layer. In most other tissues, such defects
would be rapidly repaired without untoward
consequences. However, adult articular cartilage
has only a very limited capacity to heal. Indeed,
an initially discrete lesion will not only fail to
heal, but will almost certainly enlarge with time
[1–4]. Unremitting exacerbation of this condition
will ultimately lead to a debilitating state, as
evidenced by the prevalence of diseases such as
osteoarthritis [5]. This review will delineate the
intrinsic biologic limitations undermining spon-
taneous repair of articular cartilage and evaluate
the various therapeutic approaches thus far devel-
oped to overcome these inherent constraints.Address for correspondence and reprints: Ernst B. Hunziker,
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Articular cartilage defects are classified as
being either partial- or full-thickness. The former15lie entirely within the confines of cartilage tissue
itself and do not penetrate beyond the calcified
cartilage into subchondral bone; they thus cannot
be accessed by blood-bone cells, nor by macro-
phages or mesenchymal stem cells located within
the bone-marrow space. Hence, not unexpectedly,
when a partial-thickness defect is artificially
created in articular cartilage, no fibrin clot forms
within its void, and there is, furthermore, little or
no evidence of cell migration therein. The lesion
does not heal [1–4], and its appearance several
months after injury is similar to that observed at
the outset; it appears to be inert [1, 3, 4, 6, 7],
unlike defects of immature articular cartilage [8,
9]. Partial-thickness lesions are analogous to the
clefts and fissures seen during the early stages of
human osteoarthritis.
Full-thickness defects span the entire depth of
articular cartilage and additionally penetrate the
subchondral bone marrow; they are therefore read-
ily accessible to blood cells, macrophages and
mesenchymal cells which reside within this space
[Fig. 1(A)]. When a full-thickness defect is arti-
ficially created, blood from the marrow wells
up into the lesion, and a space-filling fibrin clot
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chymal cells subsequently appear, and these di#er-
entiate into chondrocytes [3, 10–12] [Fig. 1(A)–(D)].
Although full-thickness defects become filled with
repair tissue that bears a superficial resemblance
to hyaline cartilage [Fig. 1(B), (C)], this does not
persist. Indeed, it usually undergoes degeneration
within six to twelve months [10, 12] [Fig. 1(D)].
Repair of full-thickness defects is thus only
transient.Repair of full-thickness defectsspontaneous repair
Articular cartilage defects which penetrate
subchondral bone tissue are continuous with the
marrow space, and they are therefore accessible to
a number of natural stem cells located therein.
Spontaneous repair consistently follows the same
course, which has been characterized in detail by
Shapiro et al. [12]. The sequence of events may be
briefly summarized as follows: the void of a full-
thickness defect becomes filled with a fibrin clot
immediately after its creation. Two days later, this
is observed to adhere tenaciously to the wound
edges in the bony compartment, but not to those in
the cartilaginous one. Parallel strands of fibrin are
described to extend horizontally across the entire
width of the defect. Mesenchymal cells begin
to penetrate the fibrin clot peripherally, and, by
the fifth day, completely fill it. The horizontally
aligned fibrinous strands appear to furnish a guide
for the ingrowth of the mesenchymal cells, since
these adopt a corresponding orientation. By one
week, the fibrin clot has become almost completely
resorbed, and the defect is filled with mesenchymal
cells [Fig. 1(A)]. Between ten and fourteen days,
the mesenchymal cells di#erentiate into chondro-
cytes, which lay down a proteoglycan-rich extra-
cellular matrix. By eight weeks, the repair tissue
usually resembles cartilage [Fig. 1(B)]. By twenty-
four weeks, the surface of the healed tissue is
continuous with that of the surrounding native
cartilage [Fig. 1(C)]. By forty-eight weeks, how-
ever, signs of degeneration are apparent [Fig.
1(D)], and this process progresses unremittingly
with the advance of time. Within the bony com-
partment, osteogenesis proceeds in parallel with
chondrogenic activity in the cartilaginous one.
Subchondral bone is initially deposited along the
surfaces of the defect, but progressive accretion
leads to gradual filling of its void. By 48 weeks,
this process is complete.
Histological inspection of the junction between
repair tissue and the surrounding articular carti-lage reveals frequent points of discontinuity
between the two compartments. And even at sites
of contiguity, there exists no true integration
between repair and native articular cartilage tis-
sue, since collagen fibrils within each compart-
ment fail to intermingle with one another (as
revealed by polarized light microscopy). This bond-
ing problem is not confined to spontaneously-
healed, full-thickness defects; it represents a major
stumbling block encountered in all repair systems.
The extracellular matrix of articular cartilage is
rich in proteoglycans, some of which are known to
have anti-adhesive properties [13–15], and herein
may lie the di$culty of bonding between repair
and native tissue.
Shapiro et al. [12] and others [1], have noted,
that native articular cartilage adjacent to the
defect site becomes necrotic after surgery, and
with the exception of occasional chondrocyte-
cluster formations, no resorption or remodelling of
this tissue occurs; it remains essentially inert.
Despite the poor outcome [10, 12, 16, 17], this
spontaneous process still forms the ‘rationale’
behind a number of orthopaedic interventions
currently in use [5, 18–21].Transplantation concepts
Endeavours to promote healing of articular
cartilage lesions usually run along the lines of
transplanting biological materials, the suitability
of which have generally been evaluated on the
basis of empirical criteria. The most commonly
employed materials include osteochondral tissue,
cells of osteochondral origin and tissue or cells
with chondrogenic potential [19, 22, 23].perichondrial/periosteal grafts
The repair-promoting properties of perichon-
drial tissue were first recognized in 1925 [24], but
thirty years passed before this observation was
confirmed [25]. It was not until the 1970s that
either this or periosteal tissue was utilized as an
autotransplantation material for the induction of
healing in cartilage defects [26–29]. Since then,
this principle has been exploited in a variety of
protocols for treating articular cartilage lesions
[30–39]. Several investigators have reported an
improved healing response if the chondrogenic
potential of the perichondrial or periosteal tissue
is boosted either in vitro, prior to transplantation
[38], or postoperatively, by a passive-motion
schedule [33, 35, 36, 39, 40]. Although many of the
documented findings look promising, complete res-
toration of hyaline articular cartilage tissue
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[34]. Furthermore, attempts to prevent the detach-
ment of transplanted material by glueing or sutur-
ing it to the defect floor have been hampered by
technical di$culties. Uncontrolled calcification of
the graft may also contribute to subsequent loss. It
should be borne in mind that from a biological
point of view, the grafting of perichondrial or
periosteal tissue cannot be considered as an exclu-
sively uncompounded treatment approach, but
rather as a combined one. The repair response
triggered by such material will, of course, be super-
imposed upon, and influenced by, the spontaneous
one. The latter involves not only the welling up of
blood into the defect void and the formation of a
haematoma, but also the release of signalling sub-
stances which will a#ect the response of cells
within the transplanted material.cartilage/osteochondral grafts
Use of cartilage tissue itself as graft-material or
as part of an osteochondral transplant, dates back
to the beginning of the century [41–43], and this
concept still forms the foundation of much active
experimentation, both on an autograft [44–48] and
allograft basis [5, 19, 45, 49, 50].
As with perichondrial/periosteal grafts, the
chief problems encountered after the transplan-
tation of cartilage/osteochondral material are its
long-term stability and integration with native
tissue (particularly within the cartilaginous com-
partment). The absence of structural bonding
poses nutritional as well as functional di$culties
from the outset, and these naturally promote the
onset of tissue degeneration. This latter process
may be exacerbated when several pieces of graft
material are inserted into the defect void (such as
in mosaicplasty). Tissue destined for transplanta-
tion is sometimes stored at subzero temperatures,
and its subsequent thawing prior to grafting inevi-
tably reduces its viability [51–55]. The preparation
of graft material for open-joint surgery or arthro-
scopic procedures [47], such as mosaicplasty [46],
also involves the risk of reducing chondrocyte
viability. Tissue is transiently exposed to unphysi-
ologically high temperatures during its drilling, to
drying and potential metal-ion contamination from
the hollow cylinders used to punch it out, and to
mechanical compression during its press-fitting
into the lesion void. The translocation of tissue
from a low- to a high-weight-bearing region
may also lead to injurious compression by the
comparatively unphysiological loading at the
transplantation site. When non-autologous
material is employed, the situation may be furthercomplicated by the outbreak of immunological
reactions [56]. Despite the insu$ciency of exper-
imental evidence in support of this transplantation
principle, the clinical grafting of cartilage/
osteochondral material is nonetheless frequently
carried out nowadays [5, 46, 47, 50].cell-based transplantation systems
Cells used for the induction of cartilage repair
are applied in one of two manners: (i) embedded
within a matrix, or (ii) free in suspension.(i) Matrix-embedded cells
This transplantation system is a popular one for
which foetal chondroblasts [57, 58], chondrocytes
[59–65], perichondrial cells [66, 67] and mesen-
chymal stem cells [68, 69] have been employed. It is
generally conceived that the local conditions per-
taining within the defect space will promote
expansion of the cell population and the sub-
sequent transformation of repair tissue into
cartilage.
A number of interesting findings relating to this
transplantation principle are worthy of mention
here. An unexpected phenomenon is observed
when collagen-gel embedded allogenic chondro-
cytes are introduced into the void of full-thickness
defects [59, 70, 71]: these cells fail to hypertrophy.
‘Cartilage’ formed within the deep portion of
the grafted matrix does not therefore undergo
enchondral ossification. When bone-marrow-
derived mesenchymal stem cells are substituted for
chondrocytes in the same system [68], not only do
the former transform into the latter, but these
chondrocytes then become organized into a layer
of cartilage-like tissue which displays all stages
of di#erentiation—including the hypertrophic one.
Enchondral ossification thus proceeds rapidly and
e$ciently.
Polylactic-acid-embedded perichondrial cells
have been shown to elicit an overall repair fre-
quency of 85% in the rabbit model, but the
cartilage-like quality of the tissue formed was
variable, and none of the specimens appeared nor-
mal after one year [66, 67]. Neoformation of
subchondral bone was also inconsistent; and at
best, no more than 50% of the bony compartment
was filled at one year. Furthermore, only defects
wherein subchondral bone formation had taken
place displayed a cartilage-like tissue appearance
within the respective compartment.
In all model systems which have made use of this
transplantation principle, the results have been
variable, and the concept cannot be considered to
18 E. B. Hunziker: Articular cartilage repairFIG. 1(a–b).have advanced beyond the experimental stage.
Several factors may contribute to the variable
healing outcome. In most instances, no chondro-
genic stimulating agents are applied. Di#erentia-
tion of cells into chondrocytes and the formation
of cartilage thus depend upon the unpredictable
action of blood-associated signalling substances
present within bone-marrow-derived haematomas.
When matrix-embedded chondrocytes are grafted,
variability in healing may also reflect the degree to
which these cells have undergone dedi#erentiation
during culturing.The choice of matrix used for the implantation
of cells, and which serves as a sca#olding for
their expansion within the defect void, is also a
critical determinant of ‘success’. The matrix
should be composed of a material which is bio-
compatible, mechanically stable and amenable to
rapid remodelling; it should also possess proper-
ties which ensure its adequate adhesion to the
defect surfaces and facilitate the integration of
repair- and native-tissue matrices. Bioincompat-
ibility of the matrix may elicit a foreign body
giant cell reaction or an immunological response,
Osteoarthritis and Cartilage Vol. 7 No. 119which could delay the formation of cartilage and
bone.
Although the grafting of matrix-embedded cells
is a fairly straightforward undertaking in itself,
this transplantation principle has the disadvan-
tage of requiring surgical intervention on two
separate occasions when autologous cell popula-
tions are employed: The first when tissue is
removed for the isolation and expansion of cells inculture; the second when matrix-embedded cells
are topically applied to the joint lesion.FIG. 1(c–d).
FIG. 1. Photomicrographs illustrating the appearance of repair tissue filling spontaneously-healed full-thickness
defects, 10 days [A], 8 weeks [B], 24 weeks [C], and 48 weeks [D] after their creation. Each of the sections has been
stained with Safranin O to demonstrate proteoglycans within the extracellular matrix. [A]: At 10 days, repair tissue
still consists largely of undi#erentiated mesenchymal cells (M), but there is some evidence of cartilage formation (C)
on the right-hand side. B: defect border; D: defect; N: native cartilage. [B]: At 8 weeks, cartilage-like tissue (C) fills the
cartilaginous compartment of the defect (D). B: defect border; N: native cartilage. [C]: At 24 weeks, cartilage-like tissue
(C) within the defect (D) still appears to be healthy. B: defect border; N: native cartilage. [D]: At 48 weeks, cartilage-like
tissue within the defect (D) manifests signs of degeneration, as evidenced by its decreased a$nity for Safranin O (R)
and by the beginning of fibrillation within the collagenous network (F). B: defect border; N: native cartilage.
Reproduced with permission from Shapiro et al. [12].(ii) Autologous-chondrocyte suspensions
As is the case with all transplantation systems,
the cell-based principle cannot be considered in
terms of the grafted cell population alone; local
20 E. B. Hunziker: Articular cartilage repairbiological activity thereby set in train within the
defect surrounds must also be taken into account.
And when other tissue or materials (even a matrix)
are introduced together with the cells, then the
system should, strictly speaking, be regarded as a
combined one. The transplantation of autologous-
chondrocyte suspensions [61, 72, 73] falls within
this category, since, thus far, cells have always
been applied together with a periosteal flap. One
interesting aspect of this protocol deserves men-
tion here: In this instance, the periosteal flap is
placed, not in its customary position at the base of
the defect (with its cambial layer facing the joint
cavity), but at the top of the lesion (with its
cambial layer facing the defect void), where it is
sutured to the surrounding cartilage tissue; the
cavity below the periosteal flap is filled with
autologous, dedi#erentiated (i.e., fibroblast-like)
chondrocytes which had been expanded in vitro
[72].
The periosteal flap is inserted in this reversed
position in order to prevent the loss of trans-
planted cells from the defect void. But apart from
serving the function of a lid, the reversed perio-
steal flap establishes an unusual and interest-
ing microtopographic situation, in that a repair
response could be activated from the cambial layer
downards, towards the floor of the defect. The
system appears to produce results comparable to
those achieved using other set-ups [74]. However,
the relative contributions made by the cambial
layer of the periosteum, the transplanted dedi#er-
entiated chondrocytes and bone-marrow-derived
cells to the repair process have not been assessed.
It would also have been interesting to know
whether the insertion of a reversed periosteal flap
alone elicites a repair response, but the authors
did not undertake this experiment.
In a more recent study [75], the possible role
played by transplanted autologous-cell suspen-
sions in the repair response was evaluated in the
dog using the traditional set-up. The authors came
to the conclusion that the long-term outcome (one
to two years) of treating defects with autologous
chondrocytes did not di#er from that of controls
(periosteal flaps alone, no treatment). Such a
deduction is, however, not well founded. In this
study, postoperative animal care was not con-
trolled, and no measures were taken to ensure that
the sutured periosteal flaps were maintained in
position, by partial or complete immobilization of
the joints. Furthermore, the authors made no
attempts to ascertain (by arthroscopy or MRI)
whether the sutured flaps had indeed remained in
place after one or several months. On the basis of
our own experience (unpublished data), we knowthat such sutured flaps are inevitably lost to the
joint cavity if no preventive measures are taken. If
the periosteal flaps were lost (which they assuredly
were), then the autologous chondrocytes were too,
and it is therefore not surprising that the authors
found no di#erences between experimental and
control groups. This example points to the impor-
tance of controlling each step involved in such
studies throughout the entire experimental period.
Failure to do so renders interpretation of an
already complex situation yet more di$cult and
open to misconceptions. Other simple factors, such
as the thickness of the transplanted periosteal flap
and how it compares to the thickness of the native
hyaline articular cartilage layer, should also have
been defined. In most large animal models, the
periosteum is almost as thick as the layer of
hyaline articular cartilage itself. Hence, in the
reported animal experiments, there was unlikely
to have been su$cient space available for the
transplanted autologous chondrocytes within
the cartilaginous compartment; only within the
subchondral bone one.synthetic matrices
Synthetic matrices—preferably biodegradable
ones—serve as a sca#olding for the expansion of
transplanted cells within the defect space.
Chondrocytes or precursor cells cultured in, and
subsequently implanted within, a three-
dimensional system are more likely to remain in a
di#erentiated condition (chondrocytes) or to
undergo transformation (precursor cells). For this
reason, as well as for optimizing the numerical
density of cells and their immobilization in situ,
the application of a matrix is advocated.
A number of natural and synthetic materials
have been employed. The former group includes
fibrin [58, 63, 76, 77] and (denatured) collagen-
gelatine gels [78, 68]; the latter, carbohydrate-
based polymers, such as polylactates [65, 79–81],
polyglycolic acid [65, 79, 81, 82] and other biode-
gradable materials. Non-biodegradable matrices,
such as carbon- [22, 83, 84], dacron- [85–87], teflon-
[85, 86] and alginate-micromeshes [88], have also
been tested. Although reasonable results have
been obtained with some of the latter, they are
nonetheless foreign materials, which will in-
evitably undergo changes with time and thereby
influence local biomechanical properties. The con-
ditions for obtaining optimal long-term results are
thus compromised from the outset.
A number of investigators have also applied
matrices in the absence of seeded cells. Carbon-
[22, 83, 84], dacron- [85–87] and/or teflon-
micromeshes [85, 86], as well as methacrylate
Osteoarthritis and Cartilage Vol. 7 No. 121polymers [89], have been used in this capacity. In
some instances, these matrices have been supple-
mented with growth factors, such as transforming
growth factor-â [90] or growth hormone [91], in an
endeavour to trigger or facilitate a repair
response.
The principal advantage to be derived from fill-
ing a large full-thickness defect with a matrix is
that the critical-size limit for a spontaneous heal-
ing response can be overcome by its bridging
action. The utility of such a matrix depends, how-
ever, upon its becoming infiltrated with blood and
blood-borne material welling up from the damaged
subchondral bone and bone-marrow spaces, and
the subsequent formation of a haematoma within
its meshwork. A second matrix, i.e., a fibrin clot, is
thereby formed within the interstices of the
applied one. We are thus dealing with a composite
matrix which is seeded with cells from Nature.
Within this milieu, the blood and bone-marrow-
derived cells form a granulation tissue, which is
then resorbed and replaced by cartilage. Introduc-
tion of a matrix into the defect void thus serves as
a means of supporting the spontaneous healing
response over dimensions which exceed those
for such a reaction in Nature. The applied matrix
soaks up blood and bone-marrow-derived material,
and ensures its distribution (by a kind of capillary
attraction) throughout the entire defect void,
which thereby becomes thoroughly populated with
potential repair cells. In Nature, haematomas
formed within such large defects would shrink into
a small compass, such that considerable areas of
the void would remain devoid of blood-borne and
bone-marrow-derived cells for repair.evaluation of experimental protocols
Unfortunately, none of the numerous treatment
protocols instigated for the repair of full-thickness
articular cartilage defects can be considered as
optimal [74]. Furthermore, the tremendous inter-
group variation observed using any one particular
system render it impossible to anticipate a prospec-
tive result. Hence, much more research is required
before any of these methods can be adopted with a
reasonable expectation of enduring success.
The cartilage-like repair tissue formed spon-
taneously within defects is fibrous in nature, and
thus lacks the mechanical properties necessary for
the fulfilment of its physiological roles, even while
it persists. Many attempts have been made to
improve the quality and durability of this repair
tissue, but very little intrinsic progress has been
made thus far. In the future, criteria used to assess
the quality of repair tissue and its resemblance tohyaline articular cartilage need to be more rigor-
ous and less subjective. Only when such objective
measures are instigated can we hope to make a
meaningful comparison between data gleaned from
di#erent studies [92].
Somewhat surprisingly, virtually none of the
experimental approaches adopted take into
account the high degree of topographical organ-
ization and compartmentalization of the tissues
implicated. That is to say, although there exists
a clearly delineated stratification (hyaline
cartilage–calcified cartilage (non-vascularized
tissues)–cell-excluding border–subchondral bone
with marrow space (vascularized tissues) [93], most
transplantation and other treatment procedures
involve the introduction of a uniform population
of cells into the defect site, with the sanguine hope
that ‘Nature’ will undertake the necessary trans-
formations and sort out what should go where.
A more sophisticated, rational and systematic
approach is probably necessary for long-term suc-
cess. One such protocol would involve the intro-
duction of a cell-excluding barrier to separate
neo-formed cartilage at the appropriate level in
the defect void from the underlying bone, in
imitation of the physiological situation [94].Partial-thickness defects
Defects confined to the substance of mature
articular cartilage itself [Fig. 2(A)] do not heal
spontaneously [3–7, 95] [Fig. 2(A)]. Abortive repair
reactions have been observed to occur within
native tissue immediately below the defect sur-
faces, but these take the form of only very limited
cell proliferation or chondrocyte-cluster formation
[2, 95, 96] [Fig. 2(B)]. Only a few investigators have
described the production and exudation of an
extracellular matrix into the defect space [95], and
even in these studies, the nature of this material
was not determined. The di#erences in response to
injury observed in partial- and full-thickness
defects have fostered the belief that failure to heal
in the former case reflects an inaccessibility to
cells within the bone-marrow space. But recent
observations indicate that partial-thickness
defects do not in fact need access to bone-marrow
cells in order to undergo repair, since, under
appropriate conditions, mesenchymal cells can be
induced to migrate from the synovial membrane
and subsynovial spaces across the articular carti-
lage surface into the lesion void [94, 96, 97]. The
di$culties thus lie elsewhere.
The anti-adhesiveness of articular cartilage
matrix may pose one obstacle. Cartilage-specific
molecules, such as proteoglycans—particularly
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Osteoarthritis and Cartilage Vol. 7 No. 123FIG. 2. A series of light micrographs illustrating the appearance of partial-thickness articular cartilage defects, 4 weeks
after their creation in mature rabbits [A–D] and miniature pigs [E, F]. [A]: When left untreated, partial-thickness
lesions (D) do not heal spontaneously. N: native articular cartilage. [B]: In this high-magnification view of part of the
defect floor represented in [A], a few mesenchymal-like cells (M) occur sporadically along the defect surface (DS).
Within the native articular cartilage (N), some chondrocyte clusters (CC) are to be seen. [C]: After controlled removal
of proteoglycans from the defect surface by enzymatic digestion with chondroitinase AC, the adhesion of mesenchymal-
like repair cells (M) to the floor of the defect (DF) is enhanced, but its void (DV) does not become populated. [D]:
Addition of the mitogenic factor, insulin-like growth factor I, to chondroitinase AC-treated defects, leads to the laying
down of multilayers of mesenchymal-like repair cells (M) along the floor of the defect (DF), but not throughout its void
(DV). These cells elaborate a fibrous type of connective tissue (CT). [E]: Deposition of the space-filling biodegredable
matrix, fibrin, and concomitant application of the chemotactic/mitogenic growth factor, transforming growth factor-â,
leads to complete filling of the defect void (DV) with a primitive type of scar tissue. [F]: In this high-magnification view
of the surface of the native articular cartilage tissue bordering the defect represented in [E], tracts of mesenchymal-like
repair cells (T) are to be seen. These cells originate from the synovium and subsynovial tissue compartment, and are
presumably stimulated to migrate therefrom into the defect cavity, attracted by the chemotactic factor (transforming
growth factor-â). [A–D]: Semi-thin sections, stained with Toluidine Blue O. [E, F]: Thick, surface-polished saw-cuts,
stained with basic Fuchsine and McNeil’s Tetrachrome. Reproduced from [76] with the publisher’s permission.the small ones (e.g., decorin and biglycan)—are
known to inhibit the adhesion of cells and blood-
clot-attachment processes, both in vitro and in vivo
[13, 14, 97–99]. In a recent systematic study, this
and other intrinsic limiting factors were investi-
gated, and the principles for a simple surgical
treatment strategy developed [2, 94]. The anti-
adhesiveness of the defect surfaces was overcome
by controlled enzymatic degradation of superficial
proteoglycan molecules. This step did indeed
enhance the attachment of potential repair cells to
the walls and floor of the lesion, but its cavity did
not become populated [2, 99] [Fig. 2(C)]. The latter
finding suggested that these particular repair cells
have a low intrinsic mitotic activity. To test this
postulate, a mitogenic growth factor was intro-
duced into the system. This step led first to the
formation of multilayers of repair cells along the
defect floor and then to the laying down of a
scar-like tissue within the defect space [Fig. 2(D)].
Growth factors which proved to be useful in this
capacity included insulin-like growth factor I,
basic fibroblast growth factor and growth hor-
mone. When factors having a chemotactic, as well
as a mitogenic, e#ect [e.g., transforming growth
factor-â (at low activity levels, i.e., a few ng per ml)
and fibroblast growth factor] were employed, cell
tracks, originating from the synovial/subsynovial
spaces and migrating along the articular cartilage
surface into the defect void, were identified mor-
phologically [Fig. 2(F)]. Nevertheless, complete
filling of the lesion space was still not achieved.
This finding implied that repair cells require
spatial definition of the defect void in order to
populate it entirely. To this end, a biodegradable
matrix (i.e., a fibrin clot) was introduced at the
time of surgery, and the entire defect space
did then become sparsely populated with
mesenchymal-like cells. With time, these began
spontaneously to remodel the fibrin and replace itby a loose connective tissue [Fig. 2(E)]. The initial
enzymatic treatment step still proved to be useful,
since it not only enhanced adhesion of the fibrin-
matrix to the defect surfaces [100], but also pro-
moted integration between repair- and native
tissue along the lesion borders. Numerical cell
density remained low in this primitive repair tis-
sue, even up to one year after surgery. But it could
be improved by including a mitogenic and/or
chemotactic factor with the fibrin matrix. Such a
measure did not, however, promote tissue trans-
formation into cartilage, a step which obviously
required the timely application of a di#erentiation
factor. This was achieved by incorporating trans-
forming growth factor-â [at high (chondrogenic)
activity levels] into liposomes, which were applied
together with the biodegradable matrix at the time
of surgery. These liposomes then delivered their
contents at the critical juncture in time during the
course of healing, i.e., at the onset of matrix
remodelling [101, 102]. This final step in the treat-
ment protocol did indeed promote the formation of
a cartilage-like tissue and the healing of partial-
thickness defects [101–103] (Fig. 3).
This systematic analysis has enabled us to pin-
point the inherent constraints undermining repair
of partial-thickness articular cartilage defects and
to establish the principles of a treatment protocol
to overcome these. The advantage of this strategy
over conventional ones is that it makes use of
biological stimulators, thereby obviating the need
for transplantation.
The very high activity of the factors employed
for the repair of partial-thickness defects may not
be appropriate for full-thickness ones. Bone and
cartilage formation would be triggered simul-
taneously, and it seems unlikely that these two
tissue compartments would become separated at
the appropriate level within the joint. A tissue-
compartment-specific treatment strategy would be
24 E. B. Hunziker: Articular cartilage repairFIG. 3. Light micrographs of partial-thickness articular cartilage defects, 6 weeks after their creation in mature
miniature-pig knee joints. [A]: Untreated control. No repair tissue has formed spontaneously within the defect void (D).
The superficial (S), transitional (T), radial (R) and calcified (CC) zones of native articular cartilage are indicated. [B]:
This defect was filled with the space-filling biodegredable matrix, fibrin, containing transforming growth factor-â at
low concentration (to act in the capacity of a chemotactic/mitogenic factor), and at high concentration (to promote
tissue di#erentiation) in a liposome-encapsulated form. The defect void (D) has become completely filled with a
cartilage-like repair tissue, which is contiguous (see arrowheads) with the vicinal native articular cartilage (N). Cells
within the repair tissue have a chondrocyte-like appearance. In this example, they form somewhat larger chondrones
than is normal, but this was not a consistent finding. These chondrocytes are embedded within an extracellular matrix
which is less intensely stained than that of native tissue, indicating that its proteoglycan content is lower than normal.
The superficial (S), transitional (T), radial (R) and calcified zones of the vicinal native articular cartilage are indicated.
Thick, polished saw-cuts, surface-stained with basic Fuchsine and Toluidine Blue O.required. This could be achieved by depositing an
osteogenic matrix within the bony compartment
and functionally separating it from the articularcartilage one by means of a cell- and vessel-
excluding barrier, which would permit cartilage
tissue healing at the desired level. A barrier such
Osteoarthritis and Cartilage Vol. 7 No. 125as those used in guided-tissue regeneration con-
cepts would be an appropriate choice [94]. It is
hoped that further improvement and refinement of
this strategy for tissue-specific compartments will
lead to the delineation of a successful treatment
protocol which will promote the formation of func-
tionally normal and structurally persistent repair
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